Cite
HARVARD Citation
Jones, R. et al. (2018). Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma. Annals of oncology. pp. 1995-2002. [Online].